Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7

general

Stage II includes: IIA (T1-2, N1-2, M0, B0-1); IIB (T3, N0-2, M0, B0-1). T1: Limited patches, papules, and/or plaques covering less than 10% of the skin surface. May further stratify into T1a (patch only) vs. T1b (plaque +/- patch). T2: Patches, papules, or plaques covering 10% or more of the skin surface. May further stratify into T2a (patch only) vs. T2b (plaque +/- patch). T3: One or more tumors (equal or greater than 1 cm diameter). N0: No clinically abnormal peripheral lymph nodes; bio

12

Centers

0

Active Trials

$2.1B

Cancer Funding

Specific Cancer Types(2)

NameCenters
Stage IIIA Mycosis Fungoides/Sezary Syndrome4
Stage IIIB Mycosis Fungoides and Sezary Syndrome3

Top Centers for Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7(12)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
Memorial Sloan Kettering Cancer CenterNew York, NY
NCI Comprehensive
60.0
2
Dana-Farber Cancer InstituteBoston, MA
NCI Comprehensive
60.0
3
Stanford Cancer InstitutePalo Alto, CA
NCI Comprehensive
60.0
4
Sylvester Comprehensive Cancer CenterMiami, FL
NCI Clinical
60.0
5
Boston University Cancer CenterBoston, MA
60.0
6
Fred Hutch Cancer CenterSeattle, WA
NCI Comprehensive
—
7
City of Hope Comprehensive Cancer CenterDuarte, CA
NCI Comprehensive
—
8
USC Norris Comprehensive Cancer CenterLos Angeles, CA
NCI Comprehensive
—
9
Case Comprehensive Cancer CenterCleveland, OH
NCI Comprehensive
—
10
Cleveland Clinic Cancer CenterCleveland, OH
—
11
The University of Kansas Cancer CenterKansas City, KS
NCI Comprehensive
—
12
University of Illinois Cancer CenterChicago, IL
—

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →